Horizon Discovery announces collaboration with major pharmaceutical company on single cell RNAseq-linked CRISPR screening

Location: Cambridge, UK 28/08/2018 Co-development and implementation of a new CRISPR-based screening technology platform to address critical gaps in target ID and validation Single cell RNAseq-linked pooled CRISPR screening offers unparalleled depth of screening data and biological insight New platform will further enhance Horizon’s CRISPR screening capabilities Cambridge, UK, 28 August 2018: Horizon Discovery Group... Read more

Illumina Receives Approval of MiSeq™Dx System in China

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) today announced that its MiSeq™Dx Sequencing System received the approval certificate from the China National Drug Administration (CNDA). This is Illumina’s first CNDA-cleared, next-generation sequencing (NGS) system in China. In accordance with the clearance, Illumina can now market and sell the MiSeqDx Sequencing System to hospitals and other medical institutions... Read more

10x Genomics Acquires Epinomics

Furthers 10x Leadership across Genomics Applications; Brings Inventors of ATAC-seq Technology to 10x PLEASANTON, CA.—August 28, 2018—10x Genomics, a leader in the genomics field, today announced its first acquisition with Epinomics, a pioneer in the growing epigenetics space. The acquisition will give 10x Genomics ATAC-seq technology and fundamental IP to accelerate discoveries and further research in... Read more

NuGEN launches mRNA-Seq library preparation kits with NuQuant®, a novel library quantification method to accurately measure molar concentrations of Next-Generation Sequencing (NGS) libraries in seconds

San Carlos, CA, Aug 23, 2018 NuGEN Technologies, a leading provider of NGS library preparation solutions, today announced the launch of new mRNA-Seq library preparation kits integrated with NuQuant library quantification method. This proprietary library quantification method enables direct measurement of NGS library molar concentration, or the number of sequenceable molecules in seconds. The NuQuant method eliminates the need... Read more

Twist Bioscience Responds to Agilent’s Latest Baseless Complaint

AUG 22, 2018 Download PDF Agilent’s wholesale shift in its allegations, two and a half years into its suit, reveals only the weakness of its claims. Agilent’s most recent allegations are gamesmanship, not substance.  They omit that more than four months before it sought to change its complaint, Twist informed – and provided to Agilent – the... Read more

Agena Bioscience Announces Collaboration with PerkinElmer

21 August 2018 Combining LabChip® GX Touch Nucleic Acid Analyzer and MassARRAY® for Optimized Liquid Biopsy Workflow San Diego, CA – Agena Bioscience (Agena) announced today that they have entered into a collaboration with PerkinElmer, incorporating the LabChip® GX Touch™ nucleic acid analyzer for quality assessment and quantitation of DNA in the upfront workflow of Agena’s MassARRAY®system. The... Read more

Illumina Announces Pricing of Convertible Senior Notes

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (Nasdaq: ILMN) today announced the pricing of an offering of $650 million aggregate principal amount of its 0.0% convertible senior notes due 2023 (the “Notes”). The Notes are being offered to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Illumina has... Read more

Tecan accelerates broad genomics strategy with the acquisition of NuGEN Technologies

August 16, 2018 Acquisition of US-based NuGEN expands Tecan’s dedicated solutions offering into new market segment of next-generation sequencing (NGS) reagents and increases overall recurring revenues NuGEN provides innovative NGS kits and genomic sample prep reagents for the fastest growing field within the genomics area NuGEN to become part of Tecan’s Life Sciences Business, leveraging Tecan’s... Read more

Merck KGaA, Darmstadt, Germany, Awarded Australian CRISPR Nickase Patent for Foundational Genome-Editing Technology

Merck KGaA, Darmstadt, Germany, today announced that the Australian Patent Office has allowed the company’s patent application for the use of paired CRISPR nickases. 15 AUG 2018 | DARMSTADT, GERMANY Patent covers paired Cas9 nickase technology to reduce off-target effects, advance gene therapy and research Expands company’s foundational CRISPR cutting and integration IP necessary to correct genetic... Read more

Gyros Protein Technologies introduces Gyrolab CHO-HCP E3G Kit for impurity testing of biotherapeutics

Incorporates Cygnus Technologies’ gold standard reagents Ready-to-use immunoassay kit designed to increase productivity Uppsala, Sweden, 13 August 2018 Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, today introduced Gyrolab® CHO-HCP E3G Kit for impurity analysis in the CMC (chemistry manufacturing and controls) – bioprocess workflow of biotherapeutics.... Read more